Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee

Retrieved on: 2025-06-17 21:08:47

Tags for this article:

Click the tags to see associated articles and topics

Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee. View article details on hiswai:

Excerpt

“Interesting market. Novo never filed a patent in ... stock purchases made around Trump's 'Liberation Day' in a potential STOCK Act violation.

Article found on: fortune.com